Canostix

Canostix is developing a blood-based cancer test that combines photonics and pattern recognition, potentially beating liquid biopsy in regard to accuracy, cost and convenience. Starting with the five most common cancers, we create a constantly evolving software solution that upgrades commercially available hardware into top-of-the-line screening machines. Currently, we are raising funds to extend our proof-of-concept together with our renowned partners in India, fast-tracking clinical translation. Our goal is to introduce an affordable cancer test at the GP level that gives people certainty and enables them to act for a better quality of life.

• Employees 1
• Founded 2018